Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$34.32 - $57.55 $57,211 - $95,935
1,667 Added 23.75%
8,686 $486,000
Q3 2023

Nov 14, 2023

BUY
$40.86 - $62.98 $4,658 - $7,179
114 Added 1.65%
7,019 $289,000
Q2 2023

Aug 14, 2023

BUY
$50.96 - $58.72 $95,855 - $110,452
1,881 Added 37.44%
6,905 $385,000
Q1 2023

May 15, 2023

BUY
$35.33 - $55.79 $177,497 - $280,288
5,024 New
5,024 $280,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.